CARDIOME PHARMA CORP's ticker is CRME and the CUSIP is 14159U301. A total of 32 filers reported holding CARDIOME PHARMA CORP in Q2 2014. The put-call ratio across all filers is 1.38 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $4,220,000 | -10.3% | 500,000 | 0.0% | 0.01% | 0.0% |
| Q2 2015 | $4,705,000 | +1.3% | 500,000 | 0.0% | 0.01% | +9.1% |
| Q1 2015 | $4,645,000 | -15.9% | 500,000 | -16.7% | 0.01% | -21.4% |
| Q4 2014 | $5,524,000 | -34.8% | 600,000 | -36.8% | 0.01% | -33.3% |
| Q3 2014 | $8,469,000 | -5.0% | 950,000 | -16.1% | 0.02% | -8.7% |
| Q2 2014 | $8,917,000 | -0.6% | 1,132,260 | 0.0% | 0.02% | -4.2% |
| Q1 2014 | $8,968,000 | +6.9% | 1,132,260 | -15.0% | 0.02% | +9.1% |
| Q4 2013 | $8,386,000 | +77.2% | 1,332,260 | 0.0% | 0.02% | +57.1% |
| Q3 2013 | $4,733,000 | +82.2% | 1,332,260 | 0.0% | 0.01% | +75.0% |
| Q2 2013 | $2,598,000 | – | 1,332,260 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,241,550 | $7,520,000 | 4.03% |
| Tamarack Advisers, LP | 1,875,000 | $4,350,000 | 2.07% |
| CLOUGH CAPITAL PARTNERS L P | 2,075,663 | $4,816,000 | 0.46% |
| Rock Springs Capital Management LP | 1,200,000 | $2,784,000 | 0.12% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 4,192,034 | $9,726,000 | 0.08% |
| PUTNAM INVESTMENTS LLC | 3,092,133 | $7,174,000 | 0.02% |
| Renaissance Technologies | 528,913 | $1,227,000 | 0.00% |
| SCOTIA CAPITAL INC. | 19,120 | $44,000 | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 51,200 | $118,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 700 | $2,000 | 0.00% |